Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort
Our findings showed that CAB/RPV LAI Q8W is tolerated well in clinical practice, with high adherence to the injection schedule and few discontinuations mainly related to injection site-related pain.
Authors
- Davide Moschese (ORCID: https://orcid.org/0000-0001-5901-6742)
- Spinello Antinori (ORCID: https://orcid.org/0000-0003-0569-9407)
- Amedeo Capetti (ORCID: https://orcid.org/0000-0003-4633-1035)
- Maddalena Matone
- Andrea Giacomelli (ORCID: https://orcid.org/0000-0003-3685-4289)
- Giacomo Pozza
- Marco Piscaglia (ORCID: https://orcid.org/0000-0002-1938-1937)
- Andrea Gori (ORCID: https://orcid.org/0000-0001-6587-4794)
- Maria Vittoria Cossu (ORCID: https://orcid.org/0000-0002-6984-3028)
- Giuliano Rizzardini
- Lucia Galli (ORCID: https://orcid.org/0009-0002-4498-5414)
Institutions
- University of Milan (IT)
- Luigi Sacco Hospital (IT)
- Centre for Multidisciplinary Research in Health Science (IT)
- ASST Fatebenefratelli Sacco (IT)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1097/qai.0000000000003501
- Citations
- 2
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.59